119-hjres58
HJRES
✓ Complete Data
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Medicare Program; Calendar Year (CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin (IVIG) Items and Services Rate Update; and Other Medicare Policies".
Introduced:
Feb 12, 2025
Policy Area:
Health
Congress.gov:
Bill Statistics
4
Actions
0
Cosponsors
1
Summaries
11
Subjects
1
Text Versions
Yes
Full Text
AI Summary
AI Summary
No AI Summary Available
Click the button above to generate an AI-powered summary of this bill using Claude.
The summary will analyze the bill's key provisions, impact, and implementation details.
Error generating summary
Latest Action
Feb 12, 2025
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Summaries (1)
Introduced in House
- Feb 12, 2025
00
<p>This joint resolution nullifies the rule titled <em>Medicare Program; Calendar Year (CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin (IVIG) Items and Services Rate Update; and Other Medicare Policies</em>, which was issued by the Centers for Medicare & Medicaid Services on November 7, 2024.</p><p>The rule sets Medicare payment rates for 2025 for home health services, disposable negative pressure wound therapy (dNPWT) devices, and intravenous immune globulin (IVIG) items and services. It also specifies changes to reporting and participation requirements for providers of home health services and long-term care facilities under Medicare, including a requirement that long-term care facilities report additional data regarding acute respiratory illnesses.</p>
Actions (4)
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Type: IntroReferral
| Source: House floor actions
| Code: H11100
Feb 12, 2025
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Type: IntroReferral
| Source: House floor actions
| Code: H11100
Feb 12, 2025
Introduced in House
Type: IntroReferral
| Source: Library of Congress
| Code: Intro-H
Feb 12, 2025
Introduced in House
Type: IntroReferral
| Source: Library of Congress
| Code: 1000
Feb 12, 2025
Subjects (11)
Administrative law and regulatory procedures
Blood and blood diseases
Cardiovascular and respiratory health
Congressional oversight
Department of Health and Human Services
Health
(Policy Area)
Health care costs and insurance
Health technology, devices, supplies
Home and outpatient care
Long-term, rehabilitative, and terminal care
Medicare
Full Bill Text
Length: 2,355 characters
Version: Introduced in House
Version Date: Feb 12, 2025
Last Updated: Nov 11, 2025 6:16 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.J. Res. 58 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. J. RES. 58
Providing for congressional disapproval under chapter 8 of title 5,
United States Code, of the rule submitted by the Centers for Medicare &
Medicaid Services relating to ``Medicare Program; Calendar Year
(CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH
Quality Reporting Program Requirements; HH Value-Based Purchasing
Expanded Model Requirements; Home Intravenous Immune Globulin
(IVIG) Items and Services Rate Update; and Other Medicare Policies''.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 12, 2025
Mr. Clyde submitted the following joint resolution; which was referred
to the Committee on Ways and Means, and in addition to the Committee on
Energy and Commerce, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall
within the jurisdiction of the committee concerned
_______________________________________________________________________
JOINT RESOLUTION
Providing for congressional disapproval under chapter 8 of title 5,
United States Code, of the rule submitted by the Centers for Medicare &
Medicaid Services relating to ``Medicare Program; Calendar Year
(CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH
Quality Reporting Program Requirements; HH Value-Based Purchasing
Expanded Model Requirements; Home Intravenous Immune Globulin
(IVIG) Items and Services Rate Update; and Other Medicare Policies''.
Resolved by the Senate and House of Representatives of the United
States of America in Congress assembled, That Congress disapproves the
rule submitted by the Centers for Medicare & Medicaid Services relating
to ``Medicare Program; Calendar Year
(CY) 2025 Home Health Prospective
Payment System (HH PPS) Rate Update; HH Quality Reporting Program
Requirements; HH Value-Based Purchasing Expanded Model Requirements;
Home Intravenous Immune Globulin
(IVIG) Items and Services Rate Update;
and Other Medicare Policies'' (89 Fed. Reg. 88354 (November 7, 2024)),
and such rule shall have no force or effect.
<all>
[From the U.S. Government Publishing Office]
[H.J. Res. 58 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. J. RES. 58
Providing for congressional disapproval under chapter 8 of title 5,
United States Code, of the rule submitted by the Centers for Medicare &
Medicaid Services relating to ``Medicare Program; Calendar Year
(CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH
Quality Reporting Program Requirements; HH Value-Based Purchasing
Expanded Model Requirements; Home Intravenous Immune Globulin
(IVIG) Items and Services Rate Update; and Other Medicare Policies''.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 12, 2025
Mr. Clyde submitted the following joint resolution; which was referred
to the Committee on Ways and Means, and in addition to the Committee on
Energy and Commerce, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall
within the jurisdiction of the committee concerned
_______________________________________________________________________
JOINT RESOLUTION
Providing for congressional disapproval under chapter 8 of title 5,
United States Code, of the rule submitted by the Centers for Medicare &
Medicaid Services relating to ``Medicare Program; Calendar Year
(CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH
Quality Reporting Program Requirements; HH Value-Based Purchasing
Expanded Model Requirements; Home Intravenous Immune Globulin
(IVIG) Items and Services Rate Update; and Other Medicare Policies''.
Resolved by the Senate and House of Representatives of the United
States of America in Congress assembled, That Congress disapproves the
rule submitted by the Centers for Medicare & Medicaid Services relating
to ``Medicare Program; Calendar Year
(CY) 2025 Home Health Prospective
Payment System (HH PPS) Rate Update; HH Quality Reporting Program
Requirements; HH Value-Based Purchasing Expanded Model Requirements;
Home Intravenous Immune Globulin
(IVIG) Items and Services Rate Update;
and Other Medicare Policies'' (89 Fed. Reg. 88354 (November 7, 2024)),
and such rule shall have no force or effect.
<all>